rxstat › Shortages › Metformin Rosiglitazone

Metformin Rosiglitazone (Avandamet) shortage status

Discontinued

Source: Health Canada shortage reports · Updated Jul 9, 2026

Metformin Rosiglitazone products have been discontinued in Canada. See the reports below for which products and when.

A combination medicine used to help control blood sugar in type 2 diabetes.

Products affected
0 / 4
Reports on file
7

Reports by product

The DIN is printed on your prescription label.

Resolved
AVANDAMET
1000MG 4.00MG · TABLET · GLAXOSMITHKLINE INC
DIN 02248441 · ended Apr 20, 2017 · This product has been discontinued
Resolved
AVANDAMET
1000MG 2.00MG · TABLET · GLAXOSMITHKLINE INC
DIN 02248440 · ended Apr 20, 2017 · This product has been discontinued
Resolved
AVANDAMET
500MG 2MG · TABLET · GLAXOSMITHKLINE INC
DIN 02247086 · ended Apr 20, 2017 · This product has been discontinued
Discontinued
AVANDAMET
500MG 4MG · TABLET · GLAXOSMITHKLINE INC
DIN 02247087
Discontinued
AVANDAMET
1000MG 2.00MG · TABLET · GLAXOSMITHKLINE INC
DIN 02248440
Discontinued
AVANDAMET
1000MG 4.00MG · TABLET · GLAXOSMITHKLINE INC
DIN 02248441
Discontinued
AVANDAMET
500MG 2MG · TABLET · GLAXOSMITHKLINE INC
DIN 02247086

What's happening

One or more Metformin Rosiglitazone products have been permanently discontinued by their manufacturers. If your product is affected, ask your pharmacist about equivalent products still on the market.

Metformin Rosiglitazone is classified under “BLOOD GLUCOSE LOWERING DRUGS, EXCL. INSULINS” (ATC A10BD).

Recent changes

Common questions

What is Metformin Rosiglitazone used for?

A combination medicine used to help control blood sugar in type 2 diabetes.

When will Metformin Rosiglitazone be back in stock in Canada?

Manufacturers have not provided a reliable end date. This page updates automatically as soon as an estimate is filed.

Why is Metformin Rosiglitazone in shortage?

See the reports above; manufacturers must state a reason (most commonly manufacturing disruption or a surge in demand) when filing with Health Canada.

What can my pharmacist do about it?

Often quite a lot: substitute an equivalent product from an unaffected manufacturer, adjust quantities, or in most provinces adapt or renew prescriptions on the spot. Call your pharmacy before visiting, and call 811 for free health advice.

Email alerts

Get an email when this drug's status changes. Double opt-in, one-click unsubscribe.

Related drugs (blood glucose lowering drugs, excl. insulins)

Canagliflozin Widespread shortage 2 of 4 reported products affected · est. return Jan 8, 2027 Tirzepatide (Mounjaro) Widespread shortage 6 of 6 reported products affected Dapagliflozin Partial shortage 4 of 11 reported products affected Dapagliflozin Metformin (Xigduo) Partial shortage 2 of 6 reported products affected · est. return Dec 4, 2026 Gliclazide (Diamicron Mr) Partial shortage 2 of 20 reported products affected Metformin (Glucophage) Partial shortage 3 of 33 reported products affected

Guides: what to do when your medication is in shortage · how to read shortage reports

Data reflects reports manufacturers are legally required to file with Health Canada, republished with per-drug aggregation by rxstat. Estimated end dates are supplied by manufacturers and frequently change. This page describes drug supply only and is not medical advice; never stop or switch a medication without speaking to your pharmacist or prescriber.